Extended adjuvant therapy with neratinib plus fulvestrant blocks ER/HER2 crosstalk and maintains complete responses of ER+/HER2+ breast cancers: Implications to the ExteNET trial
| Image |  |
|---|---|
| Description | article |
| Author/s |
author: Sarah Croessmann Dhivya R Sudhan Mellissa J. Nixon Paula González Ericsson Justin M. Balko Angel Guerrero-Zotano Luigi Formisano |
| Publication date | October 1, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |